Citation 31325

TAKE,Y: INOUYE,Y: NAKAMURA,S: ALLAUDEEN,HS: KUBO,A:. (1989). COMPARATIVE STUDIES OF THE INHIBITORY PROPERTIES OF ANTIBIOTICS ON HUMAN IMMUNODEFICIENCY VIRUS AND AVIAN MYELOBLASTOSIS VIRUS REVERSE TRANSCRIPTASES AND CELLULAR DNA POLYMERASES.. 42(1)

Citation Details

Title	COMPARATIVE STUDIES OF THE INHIBITORY PROPERTIES OF ANTIBIOTICS ON HUMAN IMMUNODEFICIENCY VIRUS AND AVIAN MYELOBLASTOSIS VIRUS REVERSE TRANSCRIPTASES AND CELLULAR DNA POLYMERASES.
Authors	TAKE,Y: INOUYE,Y: NAKAMURA,S: ALLAUDEEN,HS: KUBO,A:
Year	1989
Volume	42
Issue	1

Summary

Year: 1989

Journal: Unknown

Organisms and Their Experiments (15)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA POLYMERASE ALPHA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRIAMYCIN	ACTIVE
2	DNA POLYMERASE BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRIAMYCIN	WEAK ACTIVITY
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRIAMYCIN	WEAK ACTIVITY
4	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRIAMYCIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA POLYMERASE ALPHA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COLISTIN	INACTIVE
2	DNA POLYMERASE BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COLISTIN	INACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COLISTIN	WEAK ACTIVITY
4	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COLISTIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA POLYMERASE ALPHA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ENDURACIDIN A	INACTIVE
2	DNA POLYMERASE BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ENDURACIDIN A	INACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ENDURACIDIN A	ACTIVE
4	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ENDURACIDIN A	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA POLYMERASE ALPHA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ENDURACIDIN B	INACTIVE
2	DNA POLYMERASE BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ENDURACIDIN B	INACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ENDURACIDIN B	WEAK ACTIVITY
4	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ENDURACIDIN B	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA POLYMERASE ALPHA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYSPERIN A	INACTIVE
2	DNA POLYMERASE BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYSPERIN A	INACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYSPERIN A	INACTIVE
4	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYSPERIN A	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA POLYMERASE ALPHA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	JANIEMYCIN	INACTIVE
2	DNA POLYMERASE BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	JANIEMYCIN	INACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	JANIEMYCIN	WEAK ACTIVITY
4	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	JANIEMYCIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA POLYMERASE ALPHA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THIELAVIN A	WEAK ACTIVITY
2	DNA POLYMERASE BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THIELAVIN A	INACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THIELAVIN A	INACTIVE
4	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THIELAVIN A	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA POLYMERASE ALPHA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THIELAVIN B	INACTIVE
2	DNA POLYMERASE BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THIELAVIN B	INACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THIELAVIN B	INACTIVE
4	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THIELAVIN B	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA POLYMERASE ALPHA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTONIGRIN	ACTIVE
2	DNA POLYMERASE BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTONIGRIN	WEAK ACTIVITY
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTONIGRIN	ACTIVE
4	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTONIGRIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA POLYMERASE ALPHA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SAKYOMICIN A	ACTIVE
2	DNA POLYMERASE BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SAKYOMICIN A	WEAK ACTIVITY
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SAKYOMICIN A	ACTIVE
4	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SAKYOMICIN A	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA POLYMERASE ALPHA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUZOPEPTIN A	ACTIVE
2	DNA POLYMERASE BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUZOPEPTIN A	ACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUZOPEPTIN A	ACTIVE
4	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUZOPEPTIN A	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA POLYMERASE ALPHA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUZOPEPTIN B	ACTIVE
2	DNA POLYMERASE BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUZOPEPTIN B	ACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUZOPEPTIN B	ACTIVE
4	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUZOPEPTIN B	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA POLYMERASE ALPHA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUZOPEPTIN C	ACTIVE
2	DNA POLYMERASE BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUZOPEPTIN C	ACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUZOPEPTIN C	ACTIVE
4	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUZOPEPTIN C	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA POLYMERASE ALPHA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ELLAGIC ACID	ACTIVE
2	DNA POLYMERASE BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ELLAGIC ACID	ACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ELLAGIC ACID	ACTIVE
4	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ELLAGIC ACID	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA POLYMERASE ALPHA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SURAMIN	ACTIVE
2	DNA POLYMERASE BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SURAMIN	ACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SURAMIN	ACTIVE
4	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SURAMIN	ACTIVE

Citation 31325

Citation Details

Summary

Organisms and Their Experiments (15)

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Show SPARQL Queries (1)

Query 1